These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 30201316)

  • 1. Hypertension and chronic inhibition of endocannabinoid degradation modify the endocannabinoid system and redox balance in rat heart and plasma.
    Biernacki M; Malinowska B; Timoszuk M; Toczek M; Jastrząb A; Remiszewski P; Skrzydlewska E
    Prostaglandins Other Lipid Mediat; 2018 Sep; 138():54-63. PubMed ID: 30201316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crosstalk between liver antioxidant and the endocannabinoid systems after chronic administration of the FAAH inhibitor, URB597, to hypertensive rats.
    Biernacki M; Łuczaj W; Gęgotek A; Toczek M; Bielawska K; Skrzydlewska E
    Toxicol Appl Pharmacol; 2016 Jun; 301():31-41. PubMed ID: 27086176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Redox system and phospholipid metabolism in the kidney of hypertensive rats after FAAH inhibitor URB597 administration.
    Biernacki M; Ambrożewicz E; Gęgotek A; Toczek M; Bielawska K; Skrzydlewska E
    Redox Biol; 2018 May; 15():41-50. PubMed ID: 29197803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective role of cannabinoid CB1 receptors and vascular effects of chronic administration of FAAH inhibitor URB597 in DOCA-salt hypertensive rats.
    Baranowska-Kuczko M; Kozłowska H; Kloza M; Karpińska O; Toczek M; Harasim E; Kasacka I; Malinowska B
    Life Sci; 2016 Apr; 151():288-299. PubMed ID: 26969765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic Cannabidiol Administration Fails to Diminish Blood Pressure in Rats with Primary and Secondary Hypertension Despite Its Effects on Cardiac and Plasma Endocannabinoid System, Oxidative Stress and Lipid Metabolism.
    Remiszewski P; Jarocka-Karpowicz I; Biernacki M; Jastrząb A; Schlicker E; Toczek M; Harasim-Symbor E; Pędzińska-Betiuk A; Malinowska B
    Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32075117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beneficial Changes in Rat Vascular Endocannabinoid System in Primary Hypertension and under Treatment with Chronic Inhibition of Fatty Acid Amide Hydrolase by URB597.
    Baranowska-Kuczko M; Kozłowska H; Kloza M; Harasim-Symbor E; Biernacki M; Kasacka I; Malinowska B
    Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34063297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic inhibition of fatty acid amide hydrolase by URB597 produces differential effects on cardiac performance in normotensive and hypertensive rats.
    Pędzińska-Betiuk A; Weresa J; Toczek M; Baranowska-Kuczko M; Kasacka I; Harasim-Symbor E; Malinowska B
    Br J Pharmacol; 2017 Jul; 174(13):2114-2129. PubMed ID: 28437860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The FAAH Inhibitor URB597 Modulates Lipid Mediators in the Brain of Rats with Spontaneous Hypertension.
    Biernacki M; Baranowska-Kuczko M; Niklińska GN; Skrzydlewska E
    Biomolecules; 2020 Jul; 10(7):. PubMed ID: 32664225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of chronic FAAH inhibition on myocardial lipid metabolism in normotensive and DOCA-salt hypertensive rats.
    Polak A; Harasim-Symbor E; Malinowska B; Kasacka I; Pędzińska-Betiuk A; Weresa J; Chabowski A
    Life Sci; 2017 Aug; 183():1-10. PubMed ID: 28633967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Attenuation of cue-induced reinstatement of nicotine seeking by URB597 through cannabinoid CB1 receptor in rats.
    Forget B; Guranda M; Gamaleddin I; Goldberg SR; Le Foll B
    Psychopharmacology (Berl); 2016 May; 233(10):1823-8. PubMed ID: 26864774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term administration of fatty acid amide hydrolase inhibitor (URB597) to rats with spontaneous hypertension disturbs liver redox balance and phospholipid metabolism.
    Biernacki M; Ambrożewicz E; Gęgotek A; Toczek M; Skrzydlewska E
    Adv Med Sci; 2019 Mar; 64(1):15-23. PubMed ID: 30243113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Effect of Long-Term Administration of Fatty Acid Amide Hydrolase Inhibitor URB597 on Oxidative Metabolism in the Heart of Rats with Primary and Secondary Hypertension.
    Biernacki M; Łuczaj W; Jarocka-Karpowicz I; Ambrożewicz E; Toczek M; Skrzydlewska E
    Molecules; 2018 Sep; 23(9):. PubMed ID: 30223427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Full inhibition of spinal FAAH leads to TRPV1-mediated analgesic effects in neuropathic rats and possible lipoxygenase-mediated remodeling of anandamide metabolism.
    Starowicz K; Makuch W; Korostynski M; Malek N; Slezak M; Zychowska M; Petrosino S; De Petrocellis L; Cristino L; Przewlocka B; Di Marzo V
    PLoS One; 2013; 8(4):e60040. PubMed ID: 23573230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Age-specific influences of chronic administration of the fatty acid amide hydrolase inhibitor URB597 on cardiovascular parameters and organ hypertrophy in DOCA-salt hypertensive rats.
    Toczek M; Baranowska-Kuczko M; Grzęda E; Pędzińska-Betiuk A; Weresa J; Malinowska B
    Pharmacol Rep; 2016 Apr; 68(2):363-9. PubMed ID: 26922540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic treatment with URB597 ameliorates post-stress symptoms in a rat model of PTSD.
    Fidelman S; Mizrachi Zer-Aviv T; Lange R; Hillard CJ; Akirav I
    Eur Neuropsychopharmacol; 2018 May; 28(5):630-642. PubMed ID: 29519609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of Fatty Acid Amide Hydrolase Improves Depressive-Like Behaviors Independent of Its Peripheral Antinociceptive Effects in a Rat Model of Neuropathic Pain.
    Jiang HX; Ke BW; Liu J; Ma G; Hai KR; Gong DY; Yang Z; Zhou C
    Anesth Analg; 2019 Aug; 129(2):587-597. PubMed ID: 29863609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endocannabinoids acting at cannabinoid-1 receptors regulate cardiovascular function in hypertension.
    Bátkai S; Pacher P; Osei-Hyiaman D; Radaeva S; Liu J; Harvey-White J; Offertáler L; Mackie K; Rudd MA; Bukoski RD; Kunos G
    Circulation; 2004 Oct; 110(14):1996-2002. PubMed ID: 15451779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced anxiety-like behaviour induced by genetic and pharmacological inhibition of the endocannabinoid-degrading enzyme fatty acid amide hydrolase (FAAH) is mediated by CB1 receptors.
    Moreira FA; Kaiser N; Monory K; Lutz B
    Neuropharmacology; 2008 Jan; 54(1):141-50. PubMed ID: 17709120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced function of inhibitory presynaptic cannabinoid CB1 receptors on sympathetic nerves of DOCA-salt hypertensive rats.
    Toczek M; Schlicker E; Grzęda E; Malinowska B
    Life Sci; 2015 Oct; 138():78-85. PubMed ID: 25921770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increase of brain endocannabinoid anandamide levels by FAAH inhibition and alcohol abuse behaviours in the rat.
    Cippitelli A; Cannella N; Braconi S; Duranti A; Tontini A; Bilbao A; Defonseca FR; Piomelli D; Ciccocioppo R
    Psychopharmacology (Berl); 2008 Jul; 198(4):449-60. PubMed ID: 18446329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.